annual CFF:
$5.12M-$56.56M(-91.70%)Summary
- As of today (May 24, 2025), FOLD annual cash flow from financing activities is $5.12 million, with the most recent change of -$56.56 million (-91.70%) on December 31, 2024.
- During the last 3 years, FOLD annual CFF has fallen by -$206.95 million (-97.59%).
- FOLD annual CFF is now -98.86% below its all-time high of $450.77 million, reached on December 31, 2018.
Performance
FOLD Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$11.70M-$12.80M(-1166.55%)Summary
- As of today (May 24, 2025), FOLD quarterly cash flow from financing activities is -$11.70 million, with the most recent change of -$12.80 million (-1166.55%) on March 31, 2025.
- Over the past year, FOLD quarterly CFF has increased by +$1.61 million (+12.09%).
- FOLD quarterly CFF is now -103.94% below its all-time high of $296.58 million, reached on March 31, 2018.
Performance
FOLD quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$6.73M+$1.61M(+31.42%)Summary
- As of today (May 24, 2025), FOLD TTM cash flow from financing activities is $6.73 million, with the most recent change of +$1.61 million (+31.42%) on March 31, 2025.
- Over the past year, FOLD TTM CFF has dropped by -$49.46 million (-88.02%).
- FOLD TTM CFF is now -98.80% below its all-time high of $560.66 million, reached on June 30, 2018.
Performance
FOLD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FOLD Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.7% | +12.1% | -88.0% |
| 3 y3 years | -97.6% | -43.5% | -96.5% |
| 5 y5 years | -97.7% | -686.8% | -96.6% |
FOLD Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.6% | +168.6% | -131.1% | +12.1% | -96.5% | +182.8% |
| 5 y | 5-year | -98.0% | +168.6% | -104.9% | +12.1% | -97.5% | +182.8% |
| alltime | all time | -98.9% | +168.6% | -103.9% | +12.1% | -98.8% | +182.8% |
FOLD Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$11.70M(-1166.5%) | $6.73M(+31.4%) |
| Dec 2024 | $5.12M(-91.7%) | $1.10M(-94.0%) | $5.12M(-58.1%) |
| Sep 2024 | - | $18.19M(-2222.5%) | $12.23M(-61.4%) |
| Jun 2024 | - | -$857.00K(-93.6%) | $31.66M(-43.7%) |
| Mar 2024 | - | -$13.31M(-262.1%) | $56.19M(-8.9%) |
| Dec 2023 | $61.68M(-926.4%) | $8.21M(-78.2%) | $61.68M(+14.2%) |
| Sep 2023 | - | $37.62M(+58.9%) | $54.02M(+240.9%) |
| Jun 2023 | - | $23.67M(-402.5%) | $15.85M(-322.1%) |
| Mar 2023 | - | -$7.83M(-1504.8%) | -$7.13M(-4.4%) |
| Dec 2022 | -$7.46M(-103.5%) | $557.00K(-199.6%) | -$7.46M(-8.1%) |
| Sep 2022 | - | -$559.00K(-180.7%) | -$8.12M(-104.2%) |
| Jun 2022 | - | $693.00K(-108.5%) | $193.55M(-0.8%) |
| Mar 2022 | - | -$8.15M(+7740.4%) | $195.09M(-8.0%) |
| Dec 2021 | $212.07M(-19.3%) | -$104.00K(-100.1%) | $212.07M(-9.3%) |
| Sep 2021 | - | $201.11M(+8898.3%) | $233.72M(-13.9%) |
| Jun 2021 | - | $2.23M(-74.7%) | $271.32M(-0.7%) |
| Mar 2021 | - | $8.83M(-59.0%) | $273.17M(+3.9%) |
| Dec 2020 | $262.86M(+20.9%) | $21.55M(-91.0%) | $262.86M(+7.5%) |
| Sep 2020 | - | $238.71M(+5742.2%) | $244.50M(+3773.0%) |
| Jun 2020 | - | $4.09M(-374.8%) | $6.31M(-96.8%) |
| Mar 2020 | - | -$1.49M(-146.6%) | $198.63M(-8.7%) |
| Dec 2019 | $217.50M(-51.7%) | $3.19M(+510.1%) | $217.50M(+1.3%) |
| Sep 2019 | - | $523.00K(-99.7%) | $214.67M(-40.5%) |
| Jun 2019 | - | $196.40M(+1029.8%) | $360.95M(+110.4%) |
| Mar 2019 | - | $17.38M(+4742.3%) | $171.58M(-61.9%) |
| Dec 2018 | $450.77M(+82.2%) | $359.00K(-99.8%) | $450.77M(-1.4%) |
| Sep 2018 | - | $146.80M(+1987.4%) | $457.28M(-18.4%) |
| Jun 2018 | - | $7.03M(-97.6%) | $560.66M(+3.0%) |
| Mar 2018 | - | $296.58M(+4220.8%) | $544.11M(+119.9%) |
| Dec 2017 | $247.43M(-9.3%) | $6.86M(-97.3%) | $247.43M(-36.7%) |
| Sep 2017 | - | $250.19M(-2726.9%) | $390.89M(+116.8%) |
| Jun 2017 | - | -$9.52M(>+9900.0%) | $180.34M(-34.0%) |
| Mar 2017 | - | -$95.00K(-100.1%) | $273.12M(+0.1%) |
| Dec 2016 | $272.71M(-6.2%) | $150.32M(+279.3%) | $272.71M(+122.5%) |
| Sep 2016 | - | $39.63M(-52.4%) | $122.55M(-10.2%) |
| Jun 2016 | - | $83.26M(<-9900.0%) | $136.41M(-52.4%) |
| Mar 2016 | - | -$502.00K(-432.5%) | $286.33M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $290.89M(+109.0%) | $151.00K(-99.7%) | $290.89M(-25.3%) |
| Sep 2015 | - | $53.50M(-77.1%) | $389.39M(+8.7%) |
| Jun 2015 | - | $233.18M(+5639.0%) | $358.25M(+150.0%) |
| Mar 2015 | - | $4.06M(-95.9%) | $143.33M(+3.0%) |
| Dec 2014 | $139.18M(+373.7%) | $98.64M(+341.1%) | $139.18M(+98.2%) |
| Sep 2014 | - | $22.36M(+22.5%) | $70.21M(+47.0%) |
| Jun 2014 | - | $18.25M(<-9900.0%) | $47.75M(+62.4%) |
| Mar 2014 | - | -$85.00K(-100.3%) | $29.39M(+0.1%) |
| Dec 2013 | $29.38M(-63.9%) | $29.68M(<-9900.0%) | $29.38M(>+9900.0%) |
| Sep 2013 | - | -$100.00K(+1.0%) | $162.00K(-99.1%) |
| Jun 2013 | - | -$99.00K(-1.0%) | $18.11M(+1.8%) |
| Mar 2013 | - | -$100.00K(-121.7%) | $17.80M(-78.2%) |
| Dec 2012 | $81.48M(-8823.6%) | $461.00K(-97.4%) | $81.48M(+1.0%) |
| Sep 2012 | - | $17.85M(-4391.1%) | $80.70M(+29.0%) |
| Jun 2012 | - | -$416.00K(-100.7%) | $62.55M(-0.7%) |
| Mar 2012 | - | $63.58M(<-9900.0%) | $62.97M(-6842.1%) |
| Dec 2011 | -$934.00K(-102.1%) | -$313.00K(+3.3%) | -$934.00K(-103.4%) |
| Sep 2011 | - | -$303.00K(-6160.0%) | $27.11M(+0.3%) |
| Jun 2011 | - | $5000.00(-101.5%) | $27.04M(+1.7%) |
| Mar 2011 | - | -$323.00K(-101.2%) | $26.59M(-39.1%) |
| Dec 2010 | $43.66M(+1476.7%) | $27.73M(-7553.5%) | $43.66M(+179.8%) |
| Sep 2010 | - | -$372.00K(-16.6%) | $15.60M(-6.2%) |
| Jun 2010 | - | -$446.00K(-102.7%) | $16.63M(-15.9%) |
| Mar 2010 | - | $16.75M(-5222.0%) | $19.78M(+614.3%) |
| Dec 2009 | $2.77M(-377.5%) | -$327.00K(-149.8%) | $2.77M(-1.2%) |
| Sep 2009 | - | $657.00K(-75.7%) | $2.80M(+45.3%) |
| Jun 2009 | - | $2.70M(-1130.9%) | $1.93M(-271.1%) |
| Mar 2009 | - | -$262.00K(-10.9%) | -$1.13M(+12.9%) |
| Dec 2008 | -$998.00K(-101.1%) | -$294.00K(+35.5%) | -$998.00K(+0.3%) |
| Sep 2008 | - | -$217.00K(-38.7%) | -$995.00K(-3.4%) |
| Jun 2008 | - | -$354.00K(+166.2%) | -$1.03M(-101.5%) |
| Mar 2008 | - | -$133.00K(-54.3%) | $67.83M(-26.2%) |
| Dec 2007 | $91.91M(+38.9%) | -$291.00K(+15.5%) | $91.91M(-0.3%) |
| Sep 2007 | - | -$252.00K(-100.4%) | $92.20M(-0.3%) |
| Jun 2007 | - | $68.51M(+186.1%) | $92.45M(+286.1%) |
| Mar 2007 | - | $23.95M | $23.95M |
| Dec 2006 | $66.17M(+60.4%) | - | - |
| Dec 2005 | $41.25M | - | - |
FAQ
- What is Amicus Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Amicus Therapeutics?
- What is Amicus Therapeutics annual CFF year-on-year change?
- What is Amicus Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly CFF year-on-year change?
- What is Amicus Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amicus Therapeutics?
- What is Amicus Therapeutics TTM CFF year-on-year change?
What is Amicus Therapeutics annual cash flow from financing activities?
The current annual CFF of FOLD is $5.12M
What is the all time high annual CFF for Amicus Therapeutics?
Amicus Therapeutics all-time high annual cash flow from financing activities is $450.77M
What is Amicus Therapeutics annual CFF year-on-year change?
Over the past year, FOLD annual cash flow from financing activities has changed by -$56.56M (-91.70%)
What is Amicus Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of FOLD is -$11.70M
What is the all time high quarterly CFF for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly cash flow from financing activities is $296.58M
What is Amicus Therapeutics quarterly CFF year-on-year change?
Over the past year, FOLD quarterly cash flow from financing activities has changed by +$1.61M (+12.09%)
What is Amicus Therapeutics TTM cash flow from financing activities?
The current TTM CFF of FOLD is $6.73M
What is the all time high TTM CFF for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM cash flow from financing activities is $560.66M
What is Amicus Therapeutics TTM CFF year-on-year change?
Over the past year, FOLD TTM cash flow from financing activities has changed by -$49.46M (-88.02%)